We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGND icon
951
Ligand Pharmaceuticals
LGND
$5.94B
$256K ﹤0.01%
3,948
+328
+9% +$21.9K
LPX icon
952
Louisiana-Pacific
LPX
$5.35B
$256K ﹤0.01%
8,685
+8,536
+5,729% +$241K
XRAY icon
953
Dentsply Sirona
XRAY
$2.7B
$256K ﹤0.01%
4,531
-5,531
-55% -$308K
AAON icon
954
Aaon
AAON
$7.68B
$255K ﹤0.01%
7,745
+963
+14% +$31.2K
AL
955
DELISTED
Air Lease Corp
AL
$254K ﹤0.01%
5,367
– –
MSEX icon
956
Middlesex Water
MSEX
$1.08B
$254K ﹤0.01%
4,000
– –
VC icon
957
Visteon
VC
$2.85B
$252K ﹤0.01%
2,918
+128
+5% +$11.4K
EPR icon
958
EPR Properties
EPR
$4.92B
$251K ﹤0.01%
3,560
-72,698
-95% -$5.36M
PINC
959
DELISTED
Premier
PINC
$251K ﹤0.01%
6,642
– –
ARLP icon
960
Alliance Resource Partners
ARLP
$3.33B
$250K ﹤0.01%
23,135
-2,013
-8% -$24.1K
MED icon
961
Medifast
MED
$108M
$250K ﹤0.01%
2,290
+65
+3% +$6.29K
BSX icon
962
Boston Scientific
BSX
$68.5B
$249K ﹤0.01%
5,511
-288
-5% -$12.1K
NVCR icon
963
NovoCure
NVCR
$1.89B
$249K ﹤0.01%
2,969
+107
+4% +$8.64K
BAC.PRY.CL
964
DELISTED
BANK OF AMERICA CORPORATION Depositary Shares representing a 1/1,000 th interest in a share of 6.500
BAC.PRY.CL
$249K ﹤0.01%
10,000
– –
HR icon
965
Healthcare Realty
HR
$7.58B
$248K ﹤0.01%
+8,195
New +$245K
KWR icon
966
Quaker Houghton
KWR
$2.67B
$248K ﹤0.01%
1,508
-16
-1% -$2.48K
WNS
967
DELISTED
WNS Holdings
WNS
$248K ﹤0.01%
3,756
– –
FXI icon
968
iShares China Large-Cap ETF
FXI
$4.27B
$247K ﹤0.01%
5,675
-28
-0.5% -$1.17K
PB icon
969
Prosperity Bancshares
PB
$8.82B
$247K ﹤0.01%
3,458
-27
-0.8% -$1.91K
PHO icon
970
Invesco Water Resources ETF
PHO
$2.05B
$243K ﹤0.01%
6,309
-2,000
-24% -$74.2K
SLF icon
971
Sun Life Financial
SLF
$46.6B
$243K ﹤0.01%
5,333
+281
+6% +$12.6K
NEOG icon
972
Neogen
NEOG
$2B
$242K ﹤0.01%
7,432
+1,242
+20% +$40.8K
BURL icon
973
Burlington
BURL
$23.3B
$241K ﹤0.01%
1,057
+59
+6% +$12.3K
GL icon
974
Globe Life
GL
$13.9B
$241K ﹤0.01%
2,299
+105
+5% +$10.5K
SPOT icon
975
Spotify
SPOT
$105B
$241K ﹤0.01%
1,619
-85
-5% -$11.7K
37 38
39
40 41

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.